Rasonque's Price Sparks Cost Concerns
The article discusses concerns about the long-term sustainability of high-priced cancer drugs, citing Rasonque as an example. It suggests that future cancer treatments may be launched at similar or higher costs, raising questions about affordability and healthcare system viability.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)